Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

19 Sep 2011 07:00

RNS Number : 4315O
PZ CUSSONS PLC
19 September 2011
 



19 September 2011

 

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc today issues the following interim management statement which covers the period 1 June 2011 to 18 September 2011, in advance of its Annual General Meeting, to be held at 10:30am today.

 

Overview of financial position and performance

 

The Board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

 

Trading Update

 

Europe

 

In the UK, trading in the core washing and bathing division has been robust although margins continue to be impacted by high promotional and raw material costs. New products to be launched at higher margins over the coming months include a new Carex range featuring advanced technology that continues to kill bacteria up to two hours after use.

 

The beauty division is trading well across the three brands of Sanctuary, St Tropez and Charles Worthington with good growth in the US offsetting tougher trading conditions in some UK distribution channels. New products to be launched include a Charles Worthington 'Salon at Home' range which will go into distribution in the UK and US over the coming months.

 

Performance in Poland and Greece has also been in line with expectations.

 

Asia

 

The positive momentum experienced in Indonesia in the second half of last year has continued with further growth in revenue and profitability.

 

Performance in Indonesia is helping to offset poorer trading conditions in Australia which have continued to worsen in our core categories with profitability further impacted by higher raw material costs.

 

Africa

 

The positive growth momentum has also continued in Nigeria across all business units of Home and Personal Care (HPC), Electricals and Food and Nutrition, although margins in HPC in particular have been impacted by the full effect of the continued rise in raw material costs.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on schedule with completion due by the end of the 2012 calendar year.

 

Financial Position

 

The financial position of the Group is strong with a continuing net funds position. Normal capital expenditure is at the level of depreciation with the only additional project being the £17m investment in the joint venture with Wilmar in Nigeria.

 

Summary

 

The overall performance and position of the Group at the end of the period is in line with management expectations.

 

Trading momentum in most markets is positive giving cause for optimism. Margins continue to be affected by raw material cost increases with initiatives underway to recover these through higher selling prices and margin improvement projects.

 

A further update on the Group's performance will be given in the interim financial statements for the six months to 30 November 2011, to be announced at the end of January 2012.

 

 

- Ends -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh

 

MHP Tel: 020 3128 8100

John Olsen /James White

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKADPPBKDQCD
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.